Page last updated: 2024-09-05

solifenacin succinate and Muscle Contraction

solifenacin succinate has been researched along with Muscle Contraction in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (66.67)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Costa, AM; Galatioto, GP; Gravina, GL; Martella, O; Ronchi, P; Vicentini, C	1
Ballarín, M; Balsa, D; Cabellos, J; Davalillo, S; Fernández, A; Lagunas, C; Pérez-Del-Pulgar, S; Salcedo, C	1
Miyata, K; Ohtake, A; Sasamata, M; Sato, S	1
Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O	1
Chess-Williams, R; Moro, C; Uchiyama, J	1
Honda, K; Ikeda, K; Kobayashi, S; Miyata, K; Suzuki, M; Takeuchi, M; Yamada, T	1
Ikeda, K; Naito, R; Okamoto, Y; Takeuchi, M; Toyoshima, A; Yonetoku, Y	1
Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H	1
Inadome, A; Maeda, Y; Masunaga, K; Murakami, S; Satoji, Y; Sugiyama, Y; Ueda, S; Yoshida, M	1

Reviews

1 review(s) available for solifenacin succinate and Muscle Contraction

Article	Year
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgen Journal of pharmacological sciences, 2010, Volume: 112, Issue:2 Topics: Adenosine Triphosphate; Afferent Pathways; Animals; Disease Models, Animal; Humans; Muscarinic Antagonists; Muscle Contraction; Quinuclidines; Rats; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive	2010

Article

Year

The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgen

Journal of pharmacological sciences, 2010, Volume: 112, Issue:2

Topics: Adenosine Triphosphate; Afferent Pathways; Animals; Disease Models, Animal; Humans; Muscarinic Antagonists; Muscle Contraction; Quinuclidines; Rats; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive

2010

Trials

1 trial(s) available for solifenacin succinate and Muscle Contraction

Article	Year
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity. Neurourology and urodynamics, 2009, Volume: 28, Issue:1 Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Perception; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics	2009

Article

Year

Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.

Neurourology and urodynamics, 2009, Volume: 28, Issue:1

Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Perception; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics

2009

Other Studies

7 other study(ies) available for solifenacin succinate and Muscle Contraction

Article	Year
In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder. British journal of pharmacology, 2009, Volume: 156, Issue:5 Topics: Animals; Atrial Function; Benzhydryl Compounds; Benzofurans; Carbamates; Cresols; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder	2009
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity. International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive	2011
Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. Urology, 2011, Volume: 78, Issue:6 Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Carbachol; Cresols; Diamines; Mandelic Acids; Mucous Membrane; Muscarinic Antagonists; Muscle Contraction; Phenylpropanolamine; Piperidines; Pirenzepine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Stress, Mechanical; Swine; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urothelium	2011
M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:2 Topics: Animals; Benzofurans; Bradycardia; Calcium; Carbachol; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Male; Mandelic Acids; Mice; Mice, Inbred BALB C; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Pyrrolidines; Quinuclidines; Rats; Receptor, Muscarinic M3; Receptors, Muscarinic; Salivary Glands; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder	2002
Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists. Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21 Topics: Animals; Female; Models, Molecular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Quinuclidines; Radioligand Assay; Rats; Rats, Wistar; Receptor, Muscarinic M3; Saliva; Solifenacin Succinate; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines; Urinary Bladder; Urinary Incontinence	2005
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1 Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination	2007
Pharmacological effects of solifenacin on human isolated urinary bladder. Pharmacology, 2008, Volume: 82, Issue:1 Topics: Aged; Calcium Chloride; Carbachol; Dose-Response Relationship, Drug; Electric Stimulation; Female; Humans; In Vitro Techniques; Male; Microdialysis; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder	2008